SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today announced that Arthur T. Sands, M.D., Ph.D., Nurix's president and chief executive officer will participate in the following conferences in September:
- Wells Fargo Healthcare Conference
Fireside chat: Thursday, September 7, 3:00 – 3:45 p.m. ET
- Baird Global Healthcare Conference
Fireside chat: Tuesday, September 12, 12:15 – 12:45 p.m. ET
The events will be webcast live and may be accessed via ...